These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3862427)

  • 21. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of epostane on ovarian levels of progesterone, 17 beta-estradiol, prostaglandin E2, and prostaglandin F2 alpha during ovulation in the gonadotropin-primed immature rat.
    Espey LL; Adams RF; Tanaka N; Okamura H
    Endocrinology; 1990 Jul; 127(1):259-63. PubMed ID: 2361472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect upon the human myometrium during early pregnancy of prostaglandin E2 and its analogue 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulfonylamide.
    Rydnert J
    Prostaglandins; 1986 Jul; 32(1):57-61. PubMed ID: 3464043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a local effect of intracervical prostaglandin E2-gel.
    Forman A; Ulmsten U; Bányai J; Wingerup L; Uldbjerg N
    Am J Obstet Gynecol; 1982 Aug; 143(7):756-60. PubMed ID: 6954849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the efficacy of gemeprost vaginal pessaries and extra-amniotic prostaglandin E2 gel in the induction of middle trimester abortion.
    Bigrigg A; Bourne T; Read MD
    J Obstet Gynaecol (Lahore); 1990 Apr; 10(4):304-5. PubMed ID: 12283426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of inhibition of prostaglandin synthesis on cervical softening and uterine activity during ovine parturition resulting from progesterone withdrawal induced by epostane.
    Ledger WL; Webster MA; Anderson AB; Turnbull AC
    J Endocrinol; 1985 May; 105(2):227-33. PubMed ID: 3857291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal plasma estradiol and progesterone levels during therapeutic abortion induced by 16, 16 dimethyl PGE2 p-benzaldehyde semicarbazone ester.
    Tan KC; Goh VH; Karim SM; Ratnam SS; Kottegoda SR
    Prostaglandins Leukot Med; 1984 May; 14(2):215-24. PubMed ID: 6588391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early pregnancy-abortion model using sulprostone.
    Fleischer A; Schulman H; Blattner P; Jagani N; Fayemi A
    Prostaglandins; 1982 May; 23(5):643-55. PubMed ID: 7122906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracervical administration of prostaglandin E2-gel prior to therapeutic abortion: a prospective randomized double-blind study.
    Shalev E; Tsabari A; Edelstein S; Weiner E; Zuckerman H
    Int J Gynaecol Obstet; 1988 Aug; 27(1):119-22. PubMed ID: 2905287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiating effect of epostane on pregnancy terminating activity of RU 486 in the rat.
    Vanage G; Kadam PA; Bardin CW; Koide SS
    Contraception; 1993 May; 47(5):499-506. PubMed ID: 8513677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
    Thong KJ; Norman JE; Baird DT
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
    Bygdeman M; Swahn ML
    Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of progesterone secretion with trilostane for mid-trimester termination of pregnancy: randomized controlled trials.
    le Roux PA; Tregoning SK; Zinn PM; van der Spuy ZM
    Hum Reprod; 2002 Jun; 17(6):1483-9. PubMed ID: 12042266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 pessaries to facilitate first trimester aspiration termination.
    MacKenzie IZ; Fry A
    Br J Obstet Gynaecol; 1981 Oct; 88(10):1033-7. PubMed ID: 7025883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiprogestins.
    Crooij MS
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):129-32. PubMed ID: 3042493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation.
    Selinger M; MacKenzie IZ; Gillmer MD; Phipps SL; Ferguson J
    Br J Obstet Gynaecol; 1988 Jun; 95(6):596-601. PubMed ID: 3291938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.